Kannalife, Inc. Further Elucidates Mechanism of Action Behind KLS-13019, the Company's Leading Drug Candidate for the Potential Treatment of Neuropathic Pain - BioSpace

Submitted by Anonymous (not verified) on Tue, 01/14/2020 - 18:29

Kannalife, Inc. Further Elucidates Mechanism of Action Behind KLS-13019, the Company's Leading Drug Candidate for the Potential Treatment of Neuropathic Pain BioSpace

Log in to post comments